MBA Hemostasis Valve

Device Merit Medical Systems Inc
Total Payments
$67,153
Transactions
12
Doctors
8
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $187.50 1 1
2023 $811.25 4 4
2022 $270.00 1 1
2021 $27.34 2 2
2019 $65,857 4 1

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $65,857 4 98.1%
Consulting Fee $1,195 5 1.8%
Food and Beverage $101.09 3 0.2%

Top Doctors Receiving Payments for MBA Hemostasis Valve

Doctor Specialty Location Total Records
, M.D Cardiovascular Disease Washington, DC $65,857 4
, M.D Diagnostic Radiology Farmington, UT $457.50 2
, M.D Cardiovascular Disease Chicago, IL $325.00 1
Sandeep Nathan Cardiovascular Disease Chicago, IL $212.50 1
, M.D., M.P.H Cardiovascular Disease Boston, MA $200.00 1
, M.D Internal Medicine Allentown, PA $73.75 1
, M.D Cardiovascular Disease Philadelphia, PA $13.67 1
, MD Interventional Cardiology Philadelphia, PA $13.67 1

About MBA Hemostasis Valve

MBA Hemostasis Valve is a device associated with $67,153 in payments to 8 healthcare providers, recorded across 12 transactions in the CMS Open Payments database. The primary manufacturer is Merit Medical Systems Inc.

Payment data is available from 2019 to 2024. In 2024, $187.50 was paid across 1 transactions to 1 doctors.

The most common payment nature for MBA Hemostasis Valve is "Royalty or License" ($65,857, 98.1% of total).